201 related articles for article (PubMed ID: 37697248)
1. Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.
Wen R; Huang W; Song R; Qin L; Wu Y; Peng Y; Huang X; He Y; Yang H
BMC Med Imaging; 2023 Sep; 23(1):122. PubMed ID: 37697248
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.
Hu YX; Shen JX; Han J; Mao SY; Mao RS; Li Q; Li F; Guo ZX; Zhou JH
Front Oncol; 2021; 11():641195. PubMed ID: 33912456
[TBL] [Abstract][Full Text] [Related]
5. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.
Li L; Mao S; Wang J; Zheng W; Shen J; Clevert DA; Zhou J
AJR Am J Roentgenol; 2023 May; 220(5):682-691. PubMed ID: 36382914
[No Abstract] [Full Text] [Related]
8. Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
Tan Z; Teoh WC; Wong KM; Wansaicheong GK; Sandrasegaran K
Clin Imaging; 2020 Jun; 62():63-68. PubMed ID: 32070868
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
Li L; Zheng W; Wang J; Han J; Guo Z; Hu Y; Li X; Zhou J
AJR Am J Roentgenol; 2022 Sep; 219(3):434-443. PubMed ID: 35441534
[No Abstract] [Full Text] [Related]
10. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
12. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
Huang Z; Zhou P; Li S; Li K
Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
[TBL] [Abstract][Full Text] [Related]
13. Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk.
Tong WJ; Cheng MQ; Lin MX; Hu HT; Pan JM; Huang H; Wang Y; Xie XY; Lu MD; Kuang M; Huang Y; Wang W
BMC Med Imaging; 2022 Oct; 22(1):186. PubMed ID: 36309665
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract][Full Text] [Related]
15. Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
Li W; Li L; Zhuang BW; Ruan SM; Hu HT; Huang Y; Lin MX; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
Eur Radiol; 2021 Sep; 31(9):6758-6767. PubMed ID: 33675388
[TBL] [Abstract][Full Text] [Related]
16. Combination of CT/MRI LI-RADS with CEUS can improve the diagnostic performance for HCCs.
Zhou Y; Ding J; Qin Z; Long L; Zhang X; Wang F; Chen C; Wang Y; Zhou H; Jing X
Eur J Radiol; 2022 Apr; 149():110199. PubMed ID: 35196614
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of intravascular perfusion based contrast-enhanced ultrasound LI-RADS in the evaluation of hepatocellular carcinoma.
Zuo D; Yang K; Wu S
Clin Hemorheol Microcirc; 2021; 78(4):429-437. PubMed ID: 33867358
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Focal Liver Lesions by Inexperienced Radiologists.
Wang JY; Feng SY; Xu JW; Li J; Chu L; Cui XW; Dietrich CF
J Ultrasound Med; 2020 Aug; 39(8):1537-1546. PubMed ID: 32078173
[TBL] [Abstract][Full Text] [Related]
19. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
20. CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma.
Lv K; Cao X; Dong Y; Geng D; Zhang J
Ann Transl Med; 2021 Jul; 9(13):1076. PubMed ID: 34422988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]